Search results for "Heart Failure"
Tool may allow earlier detection of heart failure in the community
A tool based on three symptoms, with follow-up testing, was successfully used to detect heart failure, as well as undiagnosed atrial fibrillation, at community events in areas of socioeconomic deprivation, a British study found.
https://immattersacp.org/weekly/archives/2025/03/18/2.htm
18 Mar 2025
NT-proBNP thresholds insufficient to diagnose HF in ambulatory patients with chronic dyspnea
For every 100 patients in whom heart failure (HF) with preserved ejection fraction is suspected due to dyspnea, using currently recommended N-terminal pro-B-type natriuretic peptide (NT-proBNP) thresholds could result in approximately 39 patients being misdiagnosed.
https://immattersacp.org/weekly/archives/2025/01/28/2.htm
28 Jan 2025
Wearable sensor reduces heart failure rehospitalization, industry study finds
A temporary wearable device plus additional remote monitoring reduced heart failure readmissions by 38% among high-risk patients, a manufacturer's trial found.
https://immattersacp.org/weekly/archives/2024/10/15/4.htm
15 Oct 2024
MRAs appear effective for heart failure across the range of ejection fractions
Steroidal mineralocorticoid receptor antagonists (MRAs) (e.g., spironolactone and eplerenone) reduced risk for cardiovascular death or heart failure hospitalization in patients with heart failure and reduced ejection fraction (EF), while nonsteroidal MRAs (e.g., finerenone) seemed beneficial in those with mildly reduced or preserved EF, an individual-patient level meta-analysis found.
https://immattersacp.org/weekly/archives/2024/09/10/4.htm
10 Sep 2024
Diagnose, address cognitive impairment in heart failure patients, society says
A new scientific statement from the Heart Failure Society of America advises clinicians to be alert to clues such as difficulty with money or running out of medicine, among other recommendations.
https://immattersacp.org/weekly/archives/2024/03/19/4.htm
19 Mar 2024
Frailer heart failure patients less likely to receive guideline-recommended therapy
A prospective analysis of patients with heart failure and reduced ejection fraction in Japan found that the proportion receiving angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers, and mineralocorticoid receptor antagonists decreased as physical frailty increased.
https://immattersacp.org/weekly/archives/2023/06/20/4.htm
20 Jun 2023
Quadruple therapy for heart failure cost-effective compared to previous standard of care
Adding a sodium-glucose cotransporter-2 inhibitor to standard care had intermediate cost-effectiveness, but replacing an angiotensin-converting enzyme inhibitor with an angiotensin receptor-neprilysin inhibitor was only borderline cost-effective, a modeling study found.
https://immattersacp.org/weekly/archives/2023/06/13/1.htm
13 Jun 2023
Rapid uptitration of oral HF therapies after HF hospitalization was safe, effective across LVEF categories
A high-intensity care strategy was associated with a reduced risk of death or heart failure (HF) readmission at 180 days in patients hospitalized for acute HF, regardless of left ventricular ejection fraction (LVEF), a prespecified analysis of a randomized trial found.
https://immattersacp.org/weekly/archives/2023/05/30/4.htm
30 May 2023
AHA statement reviews efficacy, safety of CAM therapies in patients with heart failure
Potentially beneficial complementary and alternative medicine (CAM) therapies included omega-3 polyunsaturated fatty acids, coenzyme Q10, D-ribose, and L-carnitine, the American Heart Association (AHA) said.
https://immattersacp.org/weekly/archives/2022/12/13/1.htm
13 Dec 2022
Dapagliflozin associated with improved outcomes for HF with mildly reduced or preserved ejection fraction
An industry-funded study found patients with heart failure (HF) and an ejection fraction above 40% had a lower combined risk for worsening HF or cardiovascular death if they were randomly assigned to receive dapagliflozin versus placebo.
https://immattersacp.org/weekly/archives/2022/08/30/5.htm
30 Aug 2022
EHR alerts may help boost guideline-directed therapy for heart failure
An industry-funded cluster-randomized trial found that clinician alerts were associated with an over 40% increase in prescription of four recommended drug classes in patients with heart failure with reduced ejection fraction.
https://immattersacp.org/weekly/archives/2022/04/12/1.htm
12 Apr 2022
Cardiac societies issue new joint guideline on management of heart failure
The updated guideline recommends sodium-glucose cotransporter-2 inhibitors for many heart failure patients, regardless of their diabetes status, among other changes.
https://immattersacp.org/weekly/archives/2022/04/05/2.htm
5 Apr 2022
Study finds low rates of CAD testing in patients with new-onset heart failure
Of 558,322 new heart failure patients, 34.8% received coronary artery disease (CAD) testing and 9.3% received revascularization within 90 days, which fell below expectations set by current guidelines, according to authors of a study of U.S. administrative claims data.
https://immattersacp.org/weekly/archives/2022/03/01/5.htm
1 Mar 2022
Meta-analysis compares mortality benefits of heart failure treatment combinations
Patients taking an angiotensin receptor-neprilysin inhibitor, beta-blocker, mineralocorticoid receptor antagonist, and sodium-glucose cotransporter-2 inhibitor showed the greatest reduction in risk of death, the analysis of heart failure with reduced ejection fraction found.
https://immattersacp.org/weekly/archives/2021/12/14/4.htm
14 Dec 2021
ACC pathway supports neprilysin inhibitor, SGLT-2 inhibitors for heart failure with reduced ejection fraction
The American College of Cardiology (ACC) offered this update to their expert consensus decision pathway from 2017 as interim guidance to physicians while comprehensive updates to heart failure guidelines remain in development.
https://immattersacp.org/weekly/archives/2021/01/26/4.htm
26 Jan 2021
Outpatient intensification of diuretics associated with increased mortality in heart failure
A retrospective cohort study of Danish patients who were diagnosed with heart failure from 2001 to 2016 highlighted the significance of need for intensified diuretics as an indicator of worsening heart failure, the authors said.
https://immattersacp.org/weekly/archives/2020/07/21/5.htm
21 Jul 2020
Understanding heart failure in African Americans
African Americans have a higher incidence of heart disease at a younger age, and they meet fewer criteria for ideal cardiovascular health, such as nonsmoking, physical activity, and lower body mass index.
https://immattersacp.org/archives/2019/11/understanding-heart-failure-in-african-americans.htm
1 Nov 2019
Managing patients with diabetes and heart failure
Good control of diabetes in the presence of heart failure includes appropriate HbA1c targets, metformin and comprehensive lifestyle change as first-line therapy, and a team approach.
https://immattersacp.org/archives/2019/11/managing-patients-with-diabetes-and-heart-failure.htm
1 Nov 2019
Diuretics demand discussion in heart failure management
To assess a patient's ability to adhere to a diuretic regimen, consider the patient's age, level of education, and severity of symptoms, as well as health literacy, and any comorbidities.
https://immattersacp.org/archives/2019/11/diuretics-demand-discussion-in-heart-failure-management.htm
1 Nov 2019
Signs of congestion on physical exam accurately predict heart failure hospitalizations, death
The new analysis of a randomized trial reinforces the significant, ongoing clinical relevance of the physical exam in heart failure, as well as the notion that measuring natriuretic peptides does not substitute for a comprehensive physical exam for risk stratification, study authors said.
https://immattersacp.org/weekly/archives/2019/09/17/2.htm
17 Sep 2019